Gene Query: RAB29

Dataset Description Geneva Score
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 43.06
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 34.07
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 34.07
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 29.74
Role of CD133 molecule in WNT response and renal repair 28.79
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 25.95
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 24.19
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 23.42
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 23.42
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 23.4
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 23.4
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 21.89
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 21.89
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 21.82
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 21.82
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 21.71
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 20.59
AR-independent prostate cancer is sustained through FGF signaling 20.39
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 19.51
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 19.44
LNCaP treated with iBET 18.41
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 18.14
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 17.89
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 17.24
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 16.98
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 16.79
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 16.24
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 15.94
Transcriptional profiles of normal human mature B cells 15.52
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 14.88
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 14.82
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 14.77
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 13.86
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 13.71
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 13.7
RNA-seq data from human lymphoma cell lines 13.34
ChIP-seq and RNA-seq from human lymphoma cell lines 13.34
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 13.23
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 13.23
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 13.22
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 12.81
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 12.7
RNA-Seq from human ILC transitional populations 12.7
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 12.62
Trans-differentiation of human adult peripheral blood T cells into neurons 12.59
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 12.4
Overexpression of NFIB and YBX1 in MCF-7 cells 12.19
Control of prostate tumour growth by the long non-coding RNA GHSROS 12.11
Ro60-knockout cells 11.73
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 11.66
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 11.64
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 11.59
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 11.59
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 11.55
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 11.53
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 11.53
Comparing gene expression in iPSC derived RPE from control and AMD donors 11.51
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 11.5
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 11.45
Genome-wide functional assessment of enhancer activities in the human genome 11.43
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 11.28
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 11.28
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 11.26
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 11.12
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 10.95
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 10.94
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 10.92
Gene expression signatures of innate lymphoid cells from human blood 10.86
Analysis of transcriptional regulation by Myt1 and Myt1l 10.69
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 10.68
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 10.59
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 10.57
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 10.57
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 10.51
Oncogenic MYC induces a dependency on the spliceosome in human cancer 10.41
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 10.41
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 10.4
RNA-seq of young and quiescent MRC-5 human fibroblasts 10.31
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 10.21
RNA-seq of tumor cells following angiopellosis extravasation 9.9
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 9.83
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 9.66
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 9.38
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 9.27
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 9.27
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 9.18
ARID1A regulates condensin II distribution and chromosomal partition 9.18
IL-33 activates tumor stroma to promote intestinal polyposis 9.13
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 9.12
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 9.03
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 8.99
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 8.99
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 8.95
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 8.86
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 8.77
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 8.71
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 8.65
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 8.56
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 8.56
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 8.55
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 8.55
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 8.46
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 8.41
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 8.38
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 8.3
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 8.3
Characterization of human ILC2 subsets 8.26
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 8.24
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 8.1
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 8.06
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 8.05
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 8.04
CD74 role in transcription regulation 7.99
CD74 role in transcription regulation [RNA-seq] 7.99
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 7.97
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 7.97
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 7.97
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 7.89
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 7.85
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 7.82
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 7.75
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 7.71
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 7.71
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 7.65
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 7.57
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 7.57
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 7.54
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 7.48
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 7.36
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 7.36
Differentially expressed genes post knock down of lincDUSP26 7.35
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 7.34
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.31
NAPRT activation of macrophages 7.29
Identification of renal resident macrophages across species [C1] 7.25
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 7.17
HNF1 regulates critical functions of the human epididymis epithelium. 7.17
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 7.13
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 7.1
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 7.08
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 7.08
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 7.08
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 7.05
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 7.05
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 7.01
Alteration of the microRNA network during the progression of Alzheimer’s disease 6.99
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 6.99
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 6.98
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 6.95
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 6.92
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 6.88
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 6.88
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 6.86
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 6.84
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 6.84
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 6.7
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 6.7
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 6.69
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 6.62
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 6.59
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 6.57
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 6.57
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 6.51
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 6.44
Transcriptome analysis of U87 cells upon LINC00152 knockdown 6.43
RNA sequencing of human mammary epithelial cells 6.35
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 6.32
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 6.27
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 6.21
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 6.19
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 6.16
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 6.16
RNA sequencing of matched nephrectomy samples [RNA-seq] 6.16
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 6.14
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 6.14
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 6.11
Paxillin regulates genomic networks in prostate cancer [LNCaP] 6.08
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 6.07
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 6.04
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 5.99
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 5.96
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 5.95
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 5.88
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 5.88
MCF-7 as a model for functional analysis of breast cancer risk variants 5.85
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 5.84
Androgen Receptor-regulated genes in prostate cancer cells 5.83
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 5.83
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 5.82
UBC9 knockdown in bladder cancer T24 cell lines 5.81
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 5.81
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 5.81
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.73
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.73
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 5.7
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 5.7
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 5.7
mRNA differential expression analysis in a human ex vivo model of chronic wounds 5.7
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 5.69
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 5.64
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 5.63
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 5.62
Identification of a LIF-responsive replication-competent human β cell 5.6
circRNA profile in hypopharyngeal cancer 5.57
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 5.56
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.54
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.54
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 5.54
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 5.54
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 5.54
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.52
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.52
Crizotinib v. DMSO in SW480 cells 5.51
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 5.48
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 5.48
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 5.45
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 5.44
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 5.44
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 5.4
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 5.27
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 5.17
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 5.16
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 5.16
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 5.16
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 5.12
CROP-Seq in Primary Human T Cells 5.12
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 5.12
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 5.08
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 5.08
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 5.07
FOXP1 orchestration of ASD-relevant signaling pathways. 5.04
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 5.03
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 4.98
mRNA expression profile of Lymphocytes 4.98
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 4.97
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 4.96
Bone marrow derived human B cells [normal proB] 4.96
Silencing p300 in MCF7 cells to study expression and alternative splicing 4.96
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 4.92
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 4.92
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 4.91
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 4.87
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 4.87
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 4.86
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 4.86
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 4.83
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 4.82
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 4.81
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.8
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 4.77
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 4.77
Next Generation Sequencing of human SMA and healthy control Motor Neurons 4.77
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 4.75
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 4.71
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 4.67
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 4.67
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 4.66
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 4.65
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.64
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 4.64
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 4.6
RNA-seq differential expression studies: more sequence, or more replication? 4.56
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 4.56
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 4.54
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 4.54
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 4.53
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.52
RNA-sequencing of human liver tissue 4.47
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 4.43
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 4.42
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 4.38
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 4.35
SLIGRL-induced gene expression changes in NHEK cells 4.3
Gene expression profile difference among renal location in a stone former 4.29
MCF10A H-Ras RNA-Seq 4.29
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 4.22
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 4.22
HEXIM1 is induced by DHODH inhibition to suppress melanoma 4.22
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 4.22
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 4.16
Irf9 function in immunity in mouse 4.16
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 4.15
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 4.12
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 4.1
Paxillin regulates genomic networks in prostate cancer [C4-2] 4.08
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 4.05
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.0
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 3.99
Controlling for gene expression changes in transcription factor protein networks. 3.98
Stem and effector CD8 T-cells from human cancers 3.97
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.94
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 3.9
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.89
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 3.87
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 3.87
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 3.86
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 3.82
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.82
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.82
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 3.81
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 3.75
MicroRNA-125a-5p overexpression in human macrophages 3.74
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 3.71
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 3.7
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 3.7
LIN28A modulates splicing and gene expression programs in breast cancer cells 3.7
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 3.64
Transcriptome analysis of kidney organoids 3.63
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 3.63
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.59
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 3.59
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 3.58
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 3.57
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.56
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.51
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 3.48
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 3.42
WRN knockout effects upon gene expression in SW48 and OVK18 3.41
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 3.35
Identification of renal resident macrophages across species 3.33
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 3.31
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 3.31
Proteomics identifies a marker signature of MAPKi resistance in melanoma 3.3
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 3.28
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 3.28
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 3.25
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 3.19
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 3.17
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 3.17
The cytokine environment influence on human skin-derived T cells 3.1
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.1
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.1
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 3.08
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 3.07
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 3.05
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 3.03
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 3.03
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 3.0
RNA-seq analysis upon ARID1B overexpression 2.94
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.91
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.9
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.9
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.9
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 2.84
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.83
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  2.8
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 2.79
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 2.79
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 2.78
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 2.78
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.78
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.78
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 2.74
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 2.74
Dysregulated immune system networks in war veterans with PTSD 2.71
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.7
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 2.7
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 2.6
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.6
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.6
Human Treg NaCl stimulation 2.58
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.57
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 2.56
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 2.54
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 2.51
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.47
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.45
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.44
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 2.44
Gene expression of collecting duct carcinoma of the kidney 2.37
mRNA expression profile of Lymphocytes by high-throuput sequencing 2.36
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 2.34
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 2.34
Effect of PBK knockdown on C4-2 cell transcriptome 2.32
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.3
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.3
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 2.29
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 2.25
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 2.22
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.2
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.2
Human Treg IL-12 stimulation 2.2
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.2
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.18
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 2.18
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 2.15
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 2.14
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 2.12
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 2.11
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 2.09
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 2.07
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 2.07
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.05
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 2.02
Transcriptome of activated human and mouse MAIT cells 2.01
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 1.96
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 1.94
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 1.9
MAIT cell RNA sequencing 1.9
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 1.89
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 1.89
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 1.84
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.69
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 1.68
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.66
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  1.62
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.6
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 1.59
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 1.59
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 1.55
RNA editing in nascent RNA affects pre-mRNA splicing 1.51
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 1.45
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.45
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 1.4
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 1.4
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 1.38
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.38
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.33
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.28
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.27
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.27
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.17
Molecular analysis of renal cell carcinoma with unclassfied histology 1.15
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.15
Macrophage Ad5f35 PhenoMap 1.13
naive T cell heterogeneity after neonatal thymectomy 1.12
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.11
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 1.11
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.09
Disruption of GRIN2B impairs differentiation in human neurons 1.04
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 1.04
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 1.04
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 1.04
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.99
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.98
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.97
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.96
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.95
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.94
Total RNA-Seq data from leukemic patients with complex structural variants 0.93
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.91
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.89
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.87
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.86
Unique features and clinical importance of acute alloreactive immune responses 0.85
Widespread intronic polyadenylation diversifies immune cell transcriptomes 0.84
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 0.78
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.75
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 0.72
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.72
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.71
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.7
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.67
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.67
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.66
JAK dependent survival of ALK- ALCL 0.63
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.54
CDK4/6 inhibitor resistance in prostate cancer 0.54
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.52
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.52
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.52
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.5
Expression analysis of the TAF1 syndrome 0.5
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.49
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.48
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.48
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.47
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.43
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.41
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 0.39
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 0.39
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.38
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.37
STX4 Over-Expression in Human islets 0.36
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.32
Transcriptomic analysis of human macrophages in 3D 0.32
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.31
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.31
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.3
Common inflammatory pathways between NEC and Crohn's disease 0.3
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.28
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.28
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.28
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.25
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.25
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.22
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.16
Transcriptome-wide modulation of splicing by the exon junction complex 0.16
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.15
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.12
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.11
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.11
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 0.1
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 0.1
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.06
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.04
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.04
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.04
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.02
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation